Incolen New

Recall | Medicines | 01/07/2024

The marketing authorisation holder informed its customers on June 27, 2024 that the batches mentioned are being recalled due to unresolved quality issues. The risk of a possible health hazard for treated patients can be classified as insignificant. The medicinal product is authorised in Germany and placed on the market in Austria under the Austrian Act on the Import of Medicinal Products.

Name of the medicinal product Inzolen
Marketing authorisation number(s) 6072873.00.00 (DE)
CIP code 01267768, 01385120, 00059855
Marketing authorisation holder Dr. Franz Köhler Chemie
Batch number(s) 2108817, 2127151, 2127152
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-4811
Email

Further inquiry note